EVENTS 2013.
- Published in:
- 2013
- Publication type:
- Calendar
Works matching IS 14667401 AND DT 2013 AND VI 13 AND IP 4
Results: 30
1
2
Comorbidity of allergic and autoimmune disease among patients with ADHD: a nationwide population-based study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 169
- By:
- Publication type:
- Article
3
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 169
- By:
- Publication type:
- Article
4
Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 168
- Publication type:
- Article
5
Biological therapy for Crohn's disease in a liver transplant patient.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 167
- By:
- Publication type:
- Article
6
Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 167
- By:
- Publication type:
- Article
7
Kinetics of anti-hepatitis B surface antigen titers after hepatitis B vaccination in patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 166
- By:
- Publication type:
- Article
8
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-?-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 166
- By:
- Publication type:
- Article
9
Disease phenotype at diagnosis in pediatric Crohn's disease: 5-year analyses of the EUROKIDS Registry.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 165
- By:
- Publication type:
- Article
10
Portomesenteric vein thrombosis in patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 165
- By:
- Publication type:
- Article
11
Do inflammatory bowel disease therapies cause cancer?
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 164
- By:
- Publication type:
- Article
12
Total colectomy for ulcerative colitis in children: when are we operating?
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 163
- By:
- Publication type:
- Article
13
The Crohn's disease activity index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 163
- By:
- Publication type:
- Article
14
Polypectomy is adequate treatment for adenoma-like dysplastic lesions (DALMs) in Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 162
- By:
- Publication type:
- Article
15
Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 162
- By:
- Publication type:
- Article
16
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 161
- By:
- Publication type:
- Article
17
Randomised clinical trial: once- vs. twice-daily prolonged-release mesalazine for active ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 160
- By:
- Publication type:
- Article
18
Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 160
- By:
- Publication type:
- Article
19
Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis/Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 159
- By:
- Publication type:
- Article
20
The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 159
- By:
- Publication type:
- Article
21
A prospective single-centre evaluation of the intra-individual variability of faecal calprotectin in quiescent Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 158
- By:
- Publication type:
- Article
22
Endocytoscopy allows accurate in vivo differentiation of mucosal inflammatory cells in IBD: a pilot study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 157
- By:
- Publication type:
- Article
23
Complex interactions among diet, gastrointestinal transit, and gut microbiota in humanized mice.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 157
- By:
- Publication type:
- Article
24
Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 156
- By:
- Publication type:
- Article
25
Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 156
- By:
- Publication type:
- Article
26
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 155
- By:
- Publication type:
- Article
27
Loss of protein tyrosine phosphatase non-receptor type 22 regulates interferon-?-induced signaling in human monocytes.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 155
- By:
- Publication type:
- Article
28
Psychological Stress and Related Mood Disorders, and Their Therapeutic Implications in IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 143
- By:
- Publication type:
- Article
29
Maintenance Treatment of Postoperative Crohn's Disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 135
- By:
- Publication type:
- Article
30
Fecal Microbiota Transplantation: A New Therapy for IBD? Proceeding with Caution.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 13, n. 4, p. 127
- By:
- Publication type:
- Article